Chief Executive Officer (CEO)
Delaine Smith commenced with the ALLG in 2008 as the Operations Manager in a team of just 3 ALLG staff.
Under the guidance of the ALLG’s clinician based Executive committee structure, one of Delaine’s first undertakings was to adopt the Members desire to implement a Board of management structure, and implement a strategic plan for the group. With the appointment of the Board of Directors complete in 2010, Delaine was appointed the CEO, and went about formalising the ALLG’s relationship with Peter MacCallum Cancer Centre, improving the ALLG’s grants position and increasing the ALLG staffing to better improve the clinical trial program service to the Members. After a comprehensive business review, Delaine recently lead the ALLG to commence its own in-house trial centre which opened in July 2013.
Well supported by a knowledgeable Board, motivated membership, dedicated office team, and distinguished consumer panel, Delaine is progressing further the ALLG’s strategic plans in the areas of marketing, philanthropy and fundraising. A key priority for the ALLG research effort is the sustained functions of the Tissue Bank facility, which is ably led by Megan Ellis.
Delaine is currently the Chair of the Clinical Oncology Society of Australia (COSA) Executive Officer Network, and has held a range of advisory appointments in key government and industry sector.